BOEUF (Bonesupport Holding AB) Institutional Ownership: 44.50% (As of Jul. 11, 2026)


BOEUF Bonesupport Holding AB BOEUF
77 GF Score
Price $21.40
GF Value $42.63
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Institutional Ownership?

Bonesupport Holding AB BOEUF 77 Institutional Ownership is 44.50% as of Jul. 11, 2026. GuruFocus rates BOEUF with a GF Score™ of 77/100 and a GF Value™ of $42.63 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bonesupport Holding AB's institutional ownership is 44.50%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bonesupport Holding AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bonesupport Holding AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Bonesupport Holding AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB Institutional Ownership Chart

Bonesupport Holding AB Historical Data

The historical data trend for Bonesupport Holding AB can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 51.20 49.04 51.49 49.36 50.19 49.90 49.34 49.50 50.55 50.59
BOEUF
77GF Score
Bonesupport Holding AB BOEUF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 44.50% mean?
Bonesupport Holding AB (BOEUF) has a Institutional Ownership of 44.50% as of Jul. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bonesupport Holding AB and its competitors.
Is Bonesupport Holding AB's Institutional Ownership too high?
Bonesupport Holding AB's current Institutional Ownership is 44.50%. Overall, Bonesupport Holding AB has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's Institutional Ownership compare to ISRG and BDX?
Bonesupport Holding AB's Institutional Ownership of 44.50% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bonesupport Holding AB and its competitors. Bonesupport Holding AB's current Institutional Ownership is 44.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (BOEUF) is currently considered Significantly Undervalued. The stock's GF Value™ is $42.63, compared to a current price of $21.40 — trading 49.8% below its estimated fair value. The current Institutional Ownership is 44.50%. Bonesupport Holding AB's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Bonesupport Holding AB (BOEUF), the current Institutional Ownership is 44.50% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonesupport Holding AB (BOEUF) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of $21.40 is trading 49.8% below its estimated GF Value™ of $42.63. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for BOEUF:

  • Institutional Ownership: 44.50%
  • GF Value™: $42.63 vs. price of $21.40 (49.8% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the BOEUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
77GF Score

Get the complete analysis for BOEUF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.40
Price
$42.63
GF Value